期刊文献+

药物性皮炎与病毒感染的情况调查 被引量:1

The survey of drug dermatitis and virus infection
原文传递
导出
摘要 目的 通过分析在我院接受治疗的132例药物性皮炎患者的临床资料,对患者的HHV6、HHV-7疱疹病毒以及PVB19细小病毒的感染程度进行调查分析.方法 运用酶联免疫吸附法对在我院接受治疗的药物性皮炎患者以及正常对照患者的血清进行病毒抗体的检测;综合分析患者的性别、年龄、患病类型、致病药物等与病毒感染的相关性.结果 HHV-6在药物超敏反应综合征组(DIHS)、重症药疹组、一般药疹组、对照组的阳性感染率分别是31.0%、11.7%、7.3%、0%;HHV-7在药物超敏反应综合征组(DIHS)、重症药疹组、一般药疹组、对照组的阳性感染率分别是31.0%、19.35%、9.8%、10.0%;PVB19在药物超敏反应综合征组(DIHS)、重症药疹组、一般药疹组、对照组的阳性感染率分别是0%、6.4%、4.9%、6.7%.结论 HHV-6、HHV-7的感染与药物超敏反应综合征组(DIHS)、重症药疹组发病存在相关性,PVB19感染与两组发病无关,因此,药物性皮炎病情严重与病毒感染有很大联系. Objective To observe the viral infections of HHV-6,HHV-7 and PVB19 based on the clinical data of 132 patients with drug eruption treated in our hospital.Methods Viral antibody was detected using enzyme-linked immunosorbent method and the correlation was analyzed based on the patient's gender,age,disease types,pathogenic drugs and viral infection.Results The positive rates of the HHV-6 in drug hypersensitivity syndrome group (DIHS group),severe drug eruption,eruption group and control group were 31.0%,11.7%,7.3% and 0%,respectively.The positive rates of HHV-7 in drug DIHS group,severe drug eruption,eruption group,control group were 31%,19.35%,9.8% and 10%,respectively.The positive rates of PVB19 in DIHS group,severe drug eruption,eruption group,control group were 0%,6.4%,4.9% and 6.7%,respectively.Conclusions HHV-6,HHV-7 infection was closely related to the DIHSand severe drug eruption.
出处 《国际病毒学杂志》 2015年第2期83-85,共3页 International Journal of Virology
关键词 药物性皮炎 病毒 相关分析 Drug dermatitis Virus Correlation analysis
  • 相关文献

参考文献8

二级参考文献16

  • 1何志新,甘戈,王宝玺.539例药疹临床分析[J].中华皮肤科杂志,2006,39(12):703-705. 被引量:40
  • 2刘纯卉,曹莉,王侠生.丙种球蛋白联合甲泼尼龙治疗重症大疱型药疹16例临床分析[J].中国皮肤性病学杂志,2007,21(2):102-102. 被引量:9
  • 3NASSER M, BITTERMAN-DEUTSCH O, NASSAR F. Intravenous immunoglobulin for treatment of toxic epidermal necrolysis[J]. Am J Med Sci,2005,329 (2) :95 - 98.
  • 4Huang H Y, Luo X Q, Chan L S, et al. Cutaneous adverse drug reactions in a hospital-based Chinese population [J]. Clin Exp Dermatol, 2010,35(6) : 1-6.
  • 5Sushma M, Noel M V, Ritika M C, et al. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital [J]. Pharmacoepidemiol Drug Saf, 2005,14(8) :567-570.
  • 6Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines [J]. Am J Clin Pathol, 2003,120( 1 ) : 127-137.
  • 7Puavilai S, Choonhakam C. Drug eruptions in Bangkok: a 1- year study at Ramathibodl Hospital [J]. Int J Dermatol, 1998, 37(10) : 747-751.
  • 8Ozeki T, Mushiroda T, Yowang A, et al. Genome-wide association study identifies HLA-A * 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population [Jl. Hum Mol Genet, 2011, 20(5) : 1034-1041.
  • 9Wu X T, Hu F Y, An D M, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B* 1502 allele among patients in central China [J]. Epilepsy Behav, 2010,19(3) :405-408.
  • 10王侠生等 编写,上海医科大学皮肤病学教研室.皮肤病学[M]上海医科大学出版社,1993.

共引文献46

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部